About Cannarma
Cannarma is a Healthcare company based in Delhi (India) founded in 2021 by Keshav Agarwal. It operates as a provider of cannabis-based wellness products to maintain health. Cannarma has raised $86.77 thousand across 1 funding round from investors including Amity University, Zero To One Fund and Praveen Kaushik. The company has 1 employees. Cannarma was last valued at $2.13 million in November 2023. Its Indian entity Cannarma Private Limited reported revenue of ₹28.8 Lakh. Cannarma offers products and services including Hemp Pain Relief Balm, Hemp Extract Oil, and Hemp Seed Oil. Its focus areas include HealthTech, Cannabis HealthTech and Nutraceuticals. Its competitors include Vireo Health, Demetrix, Nutritional High, THE BEEMINE LAB and DEMECAN and 4 more; 6 of its 9 listed competitors have raised funding.
Company details
Cannarma, founded in 2021 in Delhi, India, focuses on healthtech, cannabis healthtech, providing healthcare solutions, and nutraceuticals. Provider of cannabis-based wellness products to maintain health. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
- Headquarters Delhi, India
- Employees 1
- Founders Keshav Agarwal
- Stage Minicorn
- SectorsHealthcare
- Website cannarma.com
- Social LinkedIn X Facebook Instagram
- Legal Name Cannarma Private Limited
- Date of Incorporation 02 Aug, 2022
- Jurisdiction Delhi, India
- Annual Revenue₹28.8 Lakh
FY 2025 · +10% YoY
- Net Loss-₹29.2 Lakh
FY 2025 · -101% margin
- EBITDA-₹28.5 Lakh
FY 2025 · -99% margin
- Total Equity Funding$86.77K (USD)
in 1 rounds
- Latest Funding Round$86.77K (USD), Seed
Nov 2023
- InvestorsAmity University
& 2 more
- Employee Count1
Associated legal entities of Cannarma
Cannarma is associated with 2 registered companies on The Company Check; the primary company is Cannarma Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Cannarma Private Limited CIN U46497DL2022PTC402690 | Active | 02 Aug 2022 | Delhi, Delhi | ₹0.3 Cr | – | 2 | View details |
| Cannarma Private Limited CIN U52311DL2022PTC402690 | – | 02 Aug 2022 | Delhi, India | – | – | – | View details |
Products & Services of Cannarma
Cannarma offers a comprehensive portfolio of products and services, including Hemp Pain Relief Balm, Hemp Extract Oil, and Hemp Seed Oil.
Balm for alleviating pain and inflammation using hemp extracts.
Oil providing CBD for stress management and wellness support.
Oil for hydrating skin and promoting hair health naturally.
Funding Insights of Cannarma
Cannarma has successfully raised a total of $86.77K through 1 strategic funding round. The most recent funding activity was a Seed round of $86.77 thousand completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $86,774
- Total Rounds 1
- Last Round Seed — $86,774
- First Round $86,774
(Nov 2023)
- Investors Count 3
All 1 funding rounds of Cannarma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2023 | $86,774 | Seed | $2.13M | Praveen Kaushik, Zero To One Fund |
| Date | Valuation | Stage |
|---|---|---|
| Nov 2023 | $2.13M | •••••••• |
Last known valuation $2.13M (Nov 2023). 3 investors in total: 2 institutional and 1 angel.
Investors in Cannarma
Cannarma has secured backing from 3 investors, including angel, institutional, and venture fund investors. Prominent investors backing the company include Amity University, Zero To One Fund and Praveen Kaushik.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment in early-stage startups is facilitated through a SEBI-registered venture capital fund across various sectors. | 2022 | 0to1fund.com | Delhi, India | |
University offering UG & PG courses across medical, IT, and other streams | 1995 | amity.edu | Noida, India | |
PK Praveen Kaushik | Founder of Mantis Technologies, active angel investor in Indian startups | – | unknown_2b56c2ec778240529 | - |
Investor details for Cannarma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Cannarma Private Limited (Cannarma)
Cannarma Private Limited is the primary company behind Cannarma. The board of Cannarma Private Limited currently have 2 directors; the longest-serving is Keshav Agarwal, appointed in 2022.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Keshav Agarwal DIN 07182796 | Director | 02 Aug 2022 | 4 yrs 2 mo | Cannarma Private Limited |
| Rohit Chauhan DIN 08737853 | Director | 02 Aug 2022 | 4 yrs 2 mo | Cannarma Private Limited |
People of Cannarma
1 people are tracked at Cannarma (1 in leadership); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership |
Complete people profiles for Cannarma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Cannarma
Figures of Cannarma Private Limited, the primary company behind Cannarma, for FY 2025. Revenue was ₹28.8 Lakh (+10% year on year). Net loss was -₹29.2 Lakh (-101% margin). EBITDA was -₹28.5 Lakh (-99% margin).
- ₹28.8 LakhRevenue · FY 2025 · +10% YoY
- -₹29.2 LakhNet loss · -101% margin
- -₹28.5 LakhEBITDA · -99% margin
- ₹11.5 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Cannarma Private Limited are on its company page.
Detailed financial statements for Cannarma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Cannarma
3 dated milestones of Cannarma across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Cannarma is founded.
- Funding First funding round of $87K.
- Milestone Reaches Minicorn status.
Competitors of Cannarma
Cannarma has 9 listed competitors in our database, 6 of them funded. They include Vireo Health, Demetrix, Nutritional High, THE BEEMINE LAB and DEMECAN, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| vireohealth.com | 2004 | Minneapolis, United States | – | – | Cannabis plants are cultivated in greenhouses for wellness product development. | |
| demetrix.com | 2017 | Berkeley, United States | $61M | 77 | Cannabinoid ingredients for pharmaceuticals are produced via fermentation technology. | |
| nutritionalhigh.com | 2004 | Toronto, Canada | – | – | Cannabis-infused products are developed, manufactured, and distributed for consumers. | |
| thebeeminelab.com | 2018 | Madrid, Spain | $1.06M | – | Cannabis-derived nutritional and wellness products are offered online. | |
| demecan.de | 2017 | Berlin, Germany | $7.64M | – | Producer of medical cannabis | |
| alphagreen.io | 2019 | Covent Garden, United Kingdom | $4.85M | 5 | Online marketplace for cannabis products treating various diseases is operated. | |
| shopbeam.com | 2018 | Boston, United States | – | 16 | Provider of fine art photography prints and books | |
| thehealthhorizons.com | 2017 | Noida, India | $928,798 | – | Hemp-based wellness products for nutrition and personal care are provided. | |
| nextevo.com | 2002 | Conshohocken, United States | $300,000 | 7 | Cannabis-derived nutritional and wellness products are provided online. |
Detailed competitors of Cannarma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cannarma
The website of Cannarma (cannarma.com) receives about 2.6K visits a month.
- Monthly visits2.6K
▼ 67.7% vs previous month
Top companies in Cannabis Health Tech Ecosystem
10 companies that operate in the same segment as Cannarma (Cannabis Health Tech Ecosystem), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Cannabis products are provided to support consumer wellness and health. | 2013 | Smiths Falls, Ontario, Canada | – | USD 204.24 M | 960 | |
Online marketplace platform for cannabis traders | 2015 | New York, New York, United States | USD 195.4 M | – | – | |
Loyalty and marketing solutions for cannabis dispensaries are provided. | 2012 | West Palm Beach, Florida, United States | USD 25.79 M | USD 22.83 M | – | |
An online marketplace for cannabis products is operated. | 2017 | Bend, Oregon, United States | USD 603 M | – | 469 | |
Online platform for cannabis strains, reviews, and ratings | 2010 | Seattle, Washington, United States | USD 40.7 M | – | – | |
Provider of cannabis products, brands, and international business development investments | 2013 | Moncton, New Brunswick, Canada | – | USD 186.16 M | 898 | |
ERP software is offered via cloud platform for cannabis operations. | 2018 | Boston, Massachusetts, United States | – | USD 110.08 M | 313 | |
Online marketplace connecting licensed cannabis vendors and dispensaries | 2015 | Chicago, Illinois, United States | USD 22.57 M | – | – | |
Enterprise software is provided for cannabis dispensary management. | 2016 | Oakland, California, United States | USD 75.5 M | USD 148.97 K | 97 | |
Proprietary medical cannabis strains are developed and offered. | 2014 | Maryland Heights, Missouri, United States | USD 156 M | – | 557 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cannarma
Complete news archive for Cannarma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cannarma
Cannarma was founded in 2021 and raised its 1st funding round 2 years after it was founded.
Cannarma is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Cannarma is a funded company, having raised a total of $86.77K across 1 funding round to date. The company's 1st funding round was a Seed of $86.77K, raised on Nov 2023.
Cannarma has 1 employees.
The primary company behind Cannarma, Cannarma Private Limited, reported revenue of ₹28.8 Lakh for FY 2025, up 10% year on year.
Cannarma, founded in 2021 in Delhi, India, focuses on healthtech, cannabis healthtech, providing healthcare solutions, and nutraceuticals. Provider of cannabis-based wellness products to maintain health. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
Cannarma's top competitors include Vireo Health, Alphargreen Group Limited and Demetrix.
Cannarma offers Hemp Pain Relief Balm, Hemp Extract Oil, and Hemp Seed Oil.
Cannarma has 3 investors. Key investors include Amity University, Zero To One Fund, and Praveen Kaushik.
The valuation of Cannarma is $2.13M as of Nov 2023.
Cannarma operates through Cannarma Private Limited.
The legal entities of Cannarma currently have 2 directors, including Keshav Agarwal, Rohit Chauhan.